Drug Database
Back to search

Poland· PL-100326371

LutaPol

A other therapeutic radiopharmaceuticals product containing lutetii chloridum [177lu], registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 8 of our 19 countries.

ATC V10X

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLutaPolATCV10XREGISTER NO.PL-100326371PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lutetii chloridum [177lu]Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lutetii chloridum [177lu] is registered in 8 of 19 countries.

Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search lutetii chloridum [177lu] products by name

Lutetii chloridum [177lu] · ATC V10X

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Lutetii chloridum [177Lu]
Manufacturer
Narodowe Centrum Badań Jądrowych
Country
Poland (PL)
ATC code
V10X
ATC class
OTHER THERAPEUTIC RADIOPHARMACEUTICALS
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991191641

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V10X

Other therapeutic radiopharmaceuticals, as other registers publish it.

All lutetii chloridum [177lu] products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f969d958-4421-452c-be78-c19316c2600b
GET /v1/drugs/f969d958-4421-452c-be78-c19316c2600b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prekursor radiofarmaceutyku, roztwór",
  "source": "urpl",
  "strength": "0,925 – 37 GBq/fiolkę",
  "packaging": "05909991191641 ¦ Lz ¦ 104228\n1 fiol.",
  "substance": "Lutetii (177Lu) Chloridum 0,925 - 37 GBq",
  "common_name": "Lutetii chloridum [177Lu]",
  "pl_product_id": "100326371",
  "pozwolenie_nr": "22081",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about lutetii chloridum [177lu].

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console